Oralsone

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Oralsone

Property Description
Active ingredient Hydrocortisone acetate
Form Oromucosal Mucoadhesive Tablet
Pharmacological class Corticosteroid (Glucocorticoid)
General purpose Alleviating localized oral inflammation
Origin Synthetic

Oralsone is a specialized prescription-only medicine identified by its core active ingredient, Hydrocortisone acetate, which places it in the corticosteroid class, specifically a glucocorticoid. This medication is clinically recognized as an anti-inflammatory drug designed for local delivery. Hydrocortisone itself is a synthetic substance derived from the natural hormone cortisol, which plays a vital role in regulating the body’s inflammatory and immune responses. The drug is primarily positioned for use in adult patient groups and stands out due to its unique delivery mechanism.

Composition and Unique Mucoadhesive Form

The formulation of Oralsone is an innovative oromucosal mucoadhesive tablet, which differentiates it from standard oral rinses or topical gels. The active substance, Hydrocortisone acetate, is the sole medicinal component (monotherapy), delivered via a topical route of administration. This preparation is specifically designed to adhere to the moist oral lining using mucoadhesive excipients, ensuring that the potent anti-inflammatory agent is concentrated exactly at the irritated site for sustained local action. This delivery method is intended to maintain prolonged contact with the target mucosa.

General Therapeutic Purpose

The general purpose of Oralsone is to provide rapid relief by exerting a powerful anti-inflammatory action and a localized immunosuppressive effect on irritated tissues. It generally helps to diminish symptoms such as pain, swelling, and redness by managing the excessive local immune reaction. This therapeutic benefit is aimed at mitigating the discomfort associated with various localized inflammatory conditions affecting the oral mucosa. Topical corticosteroids function by suppressing local inflammation, which means this medicine's primary function is centered on regulating the abnormal immune response to promote tissue soothing.

Regulatory References

  1. Topical Corticosteroids - StatPearls - NCBI Bookshelf

What side effects are possible with Oralsone?

Possible side effects and safety information

The safety characteristics of Oralsone, which contains Hydrocortisone acetate, are officially documented based on the drug's topical delivery and its pharmacological class as a glucocorticoid. The adverse reactions listed in regulatory documents are generally divided between local effects at the application site and the potential for systemic effects from the corticosteroid class.

Officially Documented Adverse Reactions

The most common adverse reactions reported in official labeling are localized. These reactions are typically categorized under Infections and Infestations and Gastrointestinal Disorders (relating to the oral cavity).

Classification Common Adverse Reactions
Infections/Infestations Oral candidiasis (thrush)
Local Effects Application site reactions (e.g., burning, irritation)

Serious Adverse Reactions and Safety Constraints

While Oralsone is designed for local action, the potential for systemic absorption requires the inclusion of warnings for serious class effects. The most significant serious concern documented is the risk of Hypothalamic-Pituitary-Adrenal (HPA) axis suppression, particularly with prolonged use. The risk of HPA axis effects, which can lead to an adrenal crisis, is officially stated to increase with the duration of therapy.

Specific regulatory restrictions outline that the medicine is generally contraindicated in the presence of systemic fungal infections and other untreated active infections due to the immunosuppressive effect of hydrocortisone. Furthermore, regulatory documents specify that special caution is required for the pediatric population and patients with severe hepatic impairment, as these groups may have increased sensitivity or altered clearance of the drug.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdosage of this medicine is generally associated with the effects of high-level or prolonged systemic exposure to the active ingredient, Hydrocortisone, a glucocorticoid. The documented effects of overexposure are categorized as either acute or chronic.

Documented Overdose Presentations

Classification Manifestations Described in Official Documents
Acute Overdose May include non-specific symptoms such as nausea, vomiting, and extreme sleepiness.
Chronic Overdose Signs resembling Cushing's syndrome (e.g., rounded, puffy face, weight gain in the trunk/upper back), high blood pressure, fluid retention, high blood sugar, and mood changes (e.g., severe depression, psychosis).

Serious outcomes documented with prolonged high-dose exposure include convulsions (seizures) and specific eye disorders like glaucoma or cataracts. In children, chronic high-dose use may result in suppression of growth.

Required Emergency Actions

If an overdose is suspected, immediately contact the Poison Control Center (1-800-222-1222).

Immediate medical help is required if severe symptoms occur:

  • Call 911 (Emergency Services) right away if the individual has collapsed, had a seizure, has trouble breathing, or cannot be awakened.

Management of overdosage is supportive and symptomatic as there is no specific chemical antidote listed in regulatory documents. Hospital assessment may include blood tests and an ECG (heart tracing) to monitor physiological stability.

Therapeutic Uses of Oralsone

What Oralsone Treats: Main Uses and Benefits

Treating Localized Painful Oral Ulcers and Inflammation

This medication is commonly used across conditions characterized by episodic and recurrent symptom patterns, primarily aphthous ulceration (mouth ulcers). It is applied in contexts where additional symptomatic support is needed, helping to address groups of symptoms that may appear suddenly or intensify over time. The product is applied in addressing distressing manifestations of pain, local swelling, and redness at the lesion site. The use is relevant for easing painful lesions, local inflammation, and oral soreness.

“This approach helps improve day-to-day comfort during symptomatic periods.”


Providing Symptomatic Relief for Acute Discomfort

The formulation generally offers symptomatic relief that may assist with maintaining a sense of stability during difficult episodes. It is often used when symptoms intensify and supportive relief is needed, especially when discomfort creates noticeable interference with daily stability. This provides support that contributes to easing the overall symptom load, helping to improve day-to-day comfort during periods when the acute manifestations interfere with routine activities.

Quick Fact: Relief for Localized Oral Pain

Eligibility and Restrictions for Use

Who can and cannot use Oralsone? — Official Regulatory Information

The eligibility for Oralsone (Hydrocortisone acetate) is governed by rules related to the drug's corticosteroid classification, defining both absolute exclusions and conditional use populations.

Eligibility scope Official Regulatory Status
Populations for whom use is allowed Primarily Adults under standard labeled conditions.
Populations for whom use is contraindicated Patients with systemic fungal infections or known hypersensitivity to any component of the product [Source 1.1].

Age-related Eligibility Rules

The safety and efficacy of the tablet form have not been established in the pediatric population, and children may be more susceptible to the systemic effects of corticosteroids [Source 1.4]. Geriatric use requires caution due to the increased risk of complications common in older age, such as osteoporosis and diabetes [Source 3.3].

Condition-Specific Eligibility Restrictions

Use requires caution and monitoring in patients with pre-existing conditions, including liver disease, renal insufficiency, hypertension, diabetes, or gastrointestinal issues like peptic ulcers or diverticulitis [Source 1.5]. Additionally, the medicine is classified as FDA Pregnancy Category C, meaning use is only warranted if the potential benefit outweighs the potential risk [Source 1.4]. Hydrocortisone is present in breast milk, requiring a careful benefit-risk assessment during lactation [Source 1.5].

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines the official interaction profile of the active substance, Hydrocortisone, as described in government regulatory documents.


Interaction Scope

Medicinal product categories with documented interactions:

  • CYP3A4 Inhibitors and CYP3A4 Inducers
  • Live or Live-attenuated Vaccines
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
  • Anticoagulants (Coumarin derivatives)
  • Hypoglycaemic Agents and Antihypertensives

Specific interacting medicines (if explicitly listed):

  • Mifepristone and Desmopressin
  • Rifampicin, Phenytoin, Phenobarbital (Inducers)
  • Ketoconazole, Clarithromycin, Erythromycin (Inhibitors)

Mechanistic basis of interactions (only if stated in label):

  • Pharmacokinetic Interaction (Metabolic Clearance): Hydrocortisone is a substrate for CYP3A4; drugs that inhibit this enzyme may increase systemic exposure, while inducers may decrease systemic exposure.
  • Pharmacodynamic Interaction (Additive/Antagonistic Effects): Interactions occur through the reinforcement of specific risks or the direct antagonism of desired effects of co-administered medicines.

Population-specific interaction notes (if applicable):

  • The effects of the corticosteroid are officially stated to be enhanced in patients with hypothyroidism or cirrhosis (liver disease) due to altered metabolism.

Interaction-related restrictions:

  • Live or Live-attenuated Vaccines are prohibited when the corticosteroid dose is immunosuppressive.
  • Co-administration with Mifepristone is a restricted combination or contraindication.
  • Grapefruit Juice and certain herbal products (e.g., St. John's Wort) are documented to alter the plasma concentrations of the active substance.

Resulting Interaction Structure

Official interaction statements:

  • Co-administration with CYP3A4 Inhibitors (e.g., ketoconazole) decreases the clearance of Hydrocortisone, resulting in increased systemic exposure.
  • Co-administration with NSAIDs or Salicylates increases the risk of gastrointestinal ulceration and hemorrhage.
  • The efficacy of Hypoglycaemic Agents and Antihypertensives is antagonized (reduced) by concurrent corticosteroid use.

Connection to the overall interaction profile (2–4 sentences): Regulatory documents define the interaction profile primarily through the agent's dependence on CYP3A4 metabolism and potential pharmacodynamic reinforcements that affect other drug classes. The profile establishes formal restrictions and contraindications with substances like live vaccines and Mifepristone to mitigate severe consequences or therapeutic antagonism. This structure applies to Hydrocortisone as a molecule, regardless of the localized nature of its administration.

Mechanism of Action

The mechanism of action for Oralsone is defined by Glucocorticoid Receptor ( GR) agonism and subsequent repression of genetic signaling, exerted via two primary mechanistic pathways at the cellular level.


Regulating Gene Expression via the Glucocorticoid Receptor ( GR)

The drug initiates its effect by acting as an agonist for the intracellular GR, which then translocates to the cell nucleus. This activated complex directly modulates gene expression via two genomic mechanisms: Transrepression of pro-inflammatory transcription factors ( NF-kappa B and AP-1) and Transactivation of anti-inflammatory proteins, like Annexin A1. This molecular modulation reduces the synthesis of pro-inflammatory mediators.


Upstream Inhibition of the Arachidonic Acid Cascade

The induced protein Annexin A1 directly inhibits the enzyme Phospholipase A2 ( PLA2), achieving an upstream blockade of the Arachidonic Acid Cascade. By halting this process, the drug prevents the synthesis of vasoactive mediators, specifically prostaglandins and leukotrienes. This cascade results in a decrease in local capillary permeability and vasodilation, which limits the accumulation of extracellular fluid and inflammatory cells within the tissue.


⏳ Mechanism Dynamics and Localized Action

The primary GR-mediated mechanism is genomic (gene-mediated), meaning it relies on sustained cellular interaction and time (hours) for protein levels to change, indicating the mechanism is time-dependent. The unique mucoadhesive formulation provides sustained local concentration and facilitates the required molecular modulation within the oral mucosal cells.

Dosage and Administration Information

How to Use Oralsone — Administration Guidelines

Oralsone (Hydrocortisone Acetate Oromucosal Tablet) is a medicine for local administration, where the active ingredient acts directly at the affected site. The administration protocols govern the route, frequency, and duration of application.


Administration Scope

Entity Detail
Route of administration Topical, applied directly to the oral mucosa (buccal route).
Dosing schedule The unit dose is one 2.5 mg tablet. The maximum daily dose is 4 tablets (10 mg total).
Frequency and duration Administered up to four times a day. The course of use is for up to 5 days and must be discontinued if the lesion heals sooner.
Timing in relation to meals Avoid eating or drinking until the tablet has fully dissolved.
Age-group administration rules The standard regimen is specified for patients aged 12 and over. For use in children younger than 12, explicit professional guidance is required.
Missed-dose rules If a dose is forgotten, use it when remembered, unless the next dose is due in less than one hour, in which case the missed tablet should be skipped.

Resulting Procedural Structure

The procedural approach involves specific steps for application. The tablet must be placed directly against the ulcer and allowed to dissolve slowly; the tablet must not be chewed or swallowed whole. An interval of 3 to 4 hours is required between administrations, ensuring that the total daily dosage limit is not exceeded. This protocol defines the use of Oralsone as a short-term, topically contained application for acute, localized conditions.

Recent Clinical Evidence

Oralsone: Recent Clinical Evidence

The research record for Oralsone, a topical hydrocortisone acetate mucoadhesive formulation, is derived from research exploring the corticosteroid class for localized inflammatory conditions in the mouth. The evidence consists mainly of Systematic Reviews and Randomized Controlled Trials (RCTs). Clinical evidence was studied for use in conditions characterized by episodic manifestations, specifically recurrent aphthous ulceration (RAU).


Design and Outcomes Examined

The overall design included short-term RCTs where the active topical corticosteroid treatment was evaluated alongside a placebo. These trials were primarily conducted among adults diagnosed with minor forms of recurrent mouth ulcers. Research examined outcomes related to physical discomfort, such as pain scoring, and acute changes, such as the time elapsed until ulcer achieved complete resolution. The use of different measurement scales for pain across trials contributes to variability, indicating that evidence quality varies across studies.


Research Limitations and Long-Term Findings

Follow-up durations for the major clinical trials were limited, typically focusing on the resolution of a single ulcer outbreak over a period of five to fourteen days. Consequently, long-term findings are not fully established in the research. Studies explored whether treatment was associated with a change in the frequency of future ulcer episodes, but findings were mixed or inconclusive regarding outcomes related to the rate of recurrence.


Evidence in Special Populations and Uncertainty

Few data are available for pediatric populations or older adults, whose inclusion in the main clinical trials has been insufficient to draw separate conclusions about patterns observed in these populations. Subgroup findings are uncertain, as the main studies were not designed to provide detailed insight into how different patient groups might respond. Clinical research does not determine whether an individual will respond similarly to the group patterns observed in the studies.

Frequently Asked Questions (FAQ)

Common questions about Oralsone (FAQ)


Q: Is Oralsone the same as other oral steroid medicines?

A: Oralsone contains hydrocortisone, which belongs to the corticosteroid (steroid) class of medicines. However, official documents describe this formulation as an oromucosal tablet intended for topical, localized use within the mouth. This localized delivery differentiates it from systemic oral steroids, which are designed to work throughout the entire body.


Q: Why do people confuse Oralsone with creams for skin problems?

A: The active ingredient in Oralsone, hydrocortisone, is a well-known anti-inflammatory agent available in many different forms, including those used to treat certain skin conditions. It is important to know that Oralsone is formulated specifically as a mucoadhesive tablet designed to stick to the moist oral lining for a localized effect, and is not for general skin application.


Q: What is the main difference between Oralsone and a regular anti-inflammatory drug?

A: Oralsone is a corticosteroid, which works by targeting the body’s immune responses and regulating gene expression (genomic action) in the affected cells to reduce inflammation. This mechanism differs from many non-steroid anti-inflammatory drugs (NSAIDs) which may work by inhibiting specific enzymes outside the cell nucleus.


Q: Does Oralsone start working right away?

A: The medicine achieves its anti-inflammatory effects through a genomic mechanism, which involves changing the levels of certain proteins in the cells over time. Because this process is time-dependent, the expected full effect is generally observed over several hours, rather than immediately after administration.


Q: How long after starting Oralsone should I expect to see an effect?

A: The way the medicine works relies on sustained cellular interaction over time. Clinical research studies commonly measure outcomes like pain reduction over a course of several days, supporting the expectation that the full therapeutic response is not instantaneous.


Q: Are there any long-term effects described for Oralsone?

A: The risk of Hypothalamic-Pituitary-Adrenal (HPA) axis suppression is a serious concern for the corticosteroid class, which official information states increases with prolonged use. Because the approved duration for Oralsone is short-term, long-term safety findings for this specific formulation are not fully established in clinical research.


Q: Why is Oralsone sometimes prescribed in a tapering schedule?

A: Tapering refers to a gradual reduction in the dosage over time. Official guidance may suggest a procedure for gradually reducing dosage to mitigate the risk of adrenocortical insufficiency (adrenal crisis), which is associated with the sudden cessation of steroid use.


Q: Is Oralsone considered a strong medication?

A: Official literature describes the active ingredient, hydrocortisone, as exerting a potent anti-inflammatory effect. Due to its classification as a powerful glucocorticoid, it is described as a potent agent for localized treatment.


Q: How do I know if I'm having a serious side effect from Oralsone?

A: Signs of a serious systemic corticosteroid effect can include unusual weakness, severe or ongoing fatigue, vomiting, and symptoms such as high blood pressure or excessive fluid retention. If severe reactions are suspected, official information underscores the need for professional review.


Q: What does it mean that Oralsone is a 'synthetic' substance?

A: Regulatory descriptions state that the active ingredient, hydrocortisone, is a synthetic glucocorticoid. This means it is a substance manufactured in a lab and is structurally derived from the natural stress hormone cortisol that the body produces.


Q: Why do official documents mention 'suppressing' the immune system?

A: Corticosteroids like hydrocortisone work by modifying the body's immune responses. The intended therapeutic purpose is to achieve a localized immunosuppressive effect to reduce inflammation, swelling, and redness. Regulatory documents also caution that this mechanism can increase the risk of infection.


Q: What drinks or foods should I avoid when I'm on Oralsone?

A: Official guidance instructs patients to avoid eating or drinking while the tablet is dissolving in the mouth. Additionally, regulatory documents note that substances like Grapefruit Juice and certain herbal products (such as St. John's Wort) have been documented to alter the concentration of the active ingredient in the bloodstream.


Q: Why is it important to follow the directions for stopping Oralsone?

A: Regulatory information indicates that suddenly stopping corticosteroid use after a period of treatment can lead to adrenocortical insufficiency (the adrenal gland cannot produce enough hormones). Following the recommended procedure for stopping the medicine helps the body's natural hormone system adjust.


Q: Can Oralsone cause changes in mood or sleep?

A: Official regulatory information for the corticosteroid class lists a range of psychiatric changes as potential side effects. These may include insomnia (difficulty sleeping), euphoria, mood swings, and, less commonly, severe emotional disturbances.


Q: What are the most commonly reported less serious side effects of Oralsone?

A: Official labeling identifies the most common adverse reactions as effects localized to the application site. These include the development of oral candidiasis (thrush) and other application site reactions such as irritation or a burning sensation.


Q: Is it common to feel jittery or energetic when taking Oralsone?

A: While individual experience varies, regulatory documents for the corticosteroid class list side effects such as euphoria and sometimes increased energy levels. These effects may be perceived by a patient as feeling more energetic or 'jittery'.


Q: Do I need to change my diet while I am taking Oralsone?

A: Corticosteroids may cause metabolic side effects, including sodium retention and fluid retention. This suggests that dietary awareness may be relevant, as is stated in regulatory sources for the class.


Q: Can taking Oralsone for a short time cause weight gain?

A: Official regulatory documents for the corticosteroid class list weight gain and increased appetite as potential side effects. The likelihood and extent of weight changes are generally related to the dosage used and the duration of therapy.


Q: Does Oralsone affect blood sugar levels?

A: Official documents state that corticosteroids can cause decreased carbohydrate tolerance and may manifest latent diabetes mellitus. Patients with existing diabetes may require adjustments to their glucose-lowering medication while using the medicine.


Q: Is Oralsone generally safe to use before surgery?

A: Corticosteroids may cause a condition known as secondary adrenocortical and pituitary unresponsiveness, especially during periods of stress such as trauma, illness, or surgery. Official guidance indicates that professional review and supportive management may be considered in these situations.


Q: Can taking Oralsone affect how I feel emotionally?

A: Official labeling lists psychic derangements as a potential side effect for the corticosteroid class. These can include changes such as mood swings, personality changes, or feeling more euphoric.


Q: Is Oralsone known to cause hair loss or skin changes?

A: Regulatory documents list dermatological side effects for the corticosteroid class, which include thinning of the skin, bruising, and small spots of bleeding. Some official sources also mention thinning of the scalp hair as a less common effect.


Q: Are there different strengths of Oralsone, and what do they mean?

A: The official unit dose for the Oralsone oromucosal tablet formulation is the 2.5 mg strength. While the active ingredient, hydrocortisone, is available in other systemic tablet strengths, the 2.5 mg mucoadhesive tablet is the strength used for this specific localized oral treatment.


Q: Is Oralsone a treatment for chronic conditions or only short-term problems?

A: Oralsone is officially approved as an adjunctive therapy for short-term administration to treat an acute episode of a localized condition. The approved duration of therapy is generally limited to a few days.


Q: Do studies support the use of Oralsone in combination with other treatments?

A: Regulatory documents indicate that hydrocortisone is frequently used as adjunctive therapy (a complementary treatment) for specific conditions. In clinical research, the effectiveness of the drug is primarily studied on its own or compared against a placebo.


Q: Can Oralsone make me feel more tired or fatigued?

A: A serious, but rare, complication associated with the improper stopping of corticosteroid therapy is adrenocortical insufficiency. Symptoms of this condition can include severe fatigue and weakness. Following administration instructions exactly is necessary to minimize this risk.


Q: Are there any warnings about driving or operating machinery while on Oralsone?

A: The corticosteroid class has documented neurological side effects that may affect concentration or motor skills, including vertigo (dizziness) and headache. Official information suggests caution when performing tasks that require mental alertness if these symptoms occur.


Q: How does the official literature describe the benefits of Oralsone?

A: Official literature describes the medicine’s purpose as providing potent anti-inflammatory effects and modifying the body's local immune responses. The expected benefits are centered on alleviating localized oral inflammation and managing acute symptoms like swelling and redness.


Q: Can I take Oralsone if I am trying to become pregnant?

A: Authoritative sources indicate there is no current evidence that hydrocortisone tablets affect fertility in men or women. However, it is standard guidance that patients who are planning or trying to get pregnant should inform a healthcare provider before use.


Q: Is Oralsone known to cause stomach upset?

A: Regulatory documents list potential gastrointestinal side effects for the corticosteroid class, which include peptic ulceration and abdominal distention. Although Oralsone is topical, the class risk is listed, and co-administration with other gastrointestinal irritants may be restricted.


Q: What information should I share with my dentist about Oralsone?

A: Official warnings note that hydrocortisone can suppress the immune system and that the body may need special support during times of stress, such as dental procedures. Sharing information is necessary because dentists manage oral infections and may perform procedures that involve stress.


Q: Can Oralsone be taken with a cold or flu?

A: Corticosteroids are generally contraindicated (should not be used) in the presence of untreated active infections because they suppress the immune system. Patients with a cold or flu are advised to seek professional review before starting or continuing the medication, as stated in regulatory information.


Q: How is the 'risk vs. benefit' profile of Oralsone generally described in official sources?

A: Official guidance on drug use is structured to encourage assessment of the benefit versus risk of the medication. The profile is generally described as being beneficial for localized, acute inflammation while carrying the class risks of systemic corticosteroid exposure, particularly regarding HPA axis suppression.


Q: Can Oralsone be used for common allergy symptoms?

A: While this specific product is for localized use in the mouth, the active ingredient, hydrocortisone, is officially indicated for the control of severe or incapacitating allergic conditions when conventional treatments are unsuccessful, demonstrating its action as an anti-allergic agent.


Q: What if I have kidney issues? Can I still use Oralsone?

A: Use of corticosteroids requires caution in patients with pre-existing conditions, including renal insufficiency (kidney issues). Official information indicates that the dose or regimen may be professionally reviewed, as these conditions can affect how the body clears the drug.


Q: What should I do if the medicine seems to stop working?

A: Regulatory guidance suggests that if a favorable response does not occur promptly, the product should be temporarily discontinued until the issue has been adequately reviewed. Any perceived lack of efficacy necessitates professional assessment, as stated in regulatory guidance.


Q: Is there a generic version of Oralsone available?

A: The active ingredient, hydrocortisone, is widely available in many FDA-approved generic tablet forms for systemic use. Whether a generic equivalent exists for the unique oromucosal mucoadhesive tablet formulation depends on regulatory approval for that specific product.

How should Oralsone be stored and disposed of?

The storage and disposal of Oralsone mucoadhesive tablets must adhere strictly to regulatory requirements to ensure product stability and safety.

Storage Requirements

Element Requirement
Temperature Store at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F). Do not freeze.
Container Must be kept in the original container and maintained with the cap tightly closed to protect it from moisture.
Child Safety Store the product out of the sight and reach of children.

Disposal Instructions

Unused or expired medication must be handled according to official guidelines. The preferred method is to use a drug take-back program or authorized collection site. If a take-back option is unavailable, the product may be mixed with an undesirable substance, such as coffee grounds, sealed in a container, and discarded in the household trash. It must not be flushed down the sink or toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Oralsone found in:

A-Z Index: